RxDoctor Payments Data

Denise Weinreb

Adult Health · Neptune, NJNPI 1184961112

Payments from drug & device makers

$604in general payments, 2019–2025

Across 35 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$182
  • Pfizer$91
  • Harmony Biosciences LLC$53
  • Sumitomo Pharma America, Inc.$49
  • Eisai Inc.$33
  • Medtronic$29
  • plus $169 from 10 others

What the payments were for

  • Food & beverage$604100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$604 in reported general payments places this provider in the 60th percentile of 1,135 adult health providers in New Jersey.

See all adult health providers in New Jersey

Medicare billing

Part B allowed, 2024
$31,757
Medicare patients
214
Services billed
256

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BriviactBrivaracetam41$68,651
AptiomEslicarbazepine Acetate44$59,379
XcopriCenobamate14$45,383
UbrelvyUbrogepant32$41,969
Nurtec OdtRimegepant Sulfate19$33,950
QuliptaAtogepant27$28,429
ZonegranZonisamide12$23,264
Aimovig AutoinjectorErenumab-Aooe26$19,474
Emgality PenGalcanezumab-Gnlm12$14,632
Lacosamide87$9,607
Emgality SyringeGalcanezumab-Gnlm12$8,557
Levetiracetam268$7,676
EliquisApixaban13$7,471
Carbamazepine ErCarbamazepine30$5,743
Oxcarbazepine62$4,959

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta$182$70,39859 claims
UCB, Inc.Briviact$19$68,65141 claims
PfizerNurtec Odt, Eliquis$91$41,42132 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,135 adult health providers in New Jersey.

Other adult health in Neptune

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →